Annual EBITDA
-$29.47 M
-$6.24 M-26.84%
31 December 2023
Summary:
NKGen Biotech Warrants annual earnings before interest, taxes, depreciation & amortization is currently -$29.47 million, with the most recent change of -$6.24 million (-26.84%) on 31 December 2023. During the last 3 years, it has fallen by -$8.77 million (-42.34%). NKGNW annual EBITDA is now -42.34% below its all-time high of -$20.70 million, reached on 31 December 2021.NKGNW EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$7.13 M
+$1.39 M+16.31%
30 June 2024
Summary:
NKGen Biotech Warrants quarterly earnings before interest, taxes, depreciation & amortization is currently -$7.13 million, with the most recent change of +$1.39 million (+16.31%) on 30 June 2024. Over the past year, it has increased by +$2.00 million (+21.91%). NKGNW quarterly EBITDA is now -46.67% below its all-time high of -$4.86 million, reached on 30 September 2023.NKGNW Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$29.65 M
-$926.00 K-3.22%
30 June 2024
Summary:
NKGen Biotech Warrants TTM earnings before interest, taxes, depreciation & amortization is currently -$29.65 million, with the most recent change of -$926.00 thousand (-3.22%) on 30 June 2024. Over the past year, it has dropped by -$9.45 million (-46.77%). NKGNW TTM EBITDA is now -395.42% below its all-time high of -$5.98 million, reached on 30 September 2022.NKGNW TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKGNW EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +21.9% | -46.8% |
| 3 y3 years | -42.3% | - | - |
| 5 y5 years | - | - | - |
NKGNW EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -42.3% | at low | -46.7% | +21.9% | -395.4% | at low |
| 5 y | 5 years | -42.3% | at low | -46.7% | +21.9% | -395.4% | at low |
| alltime | all time | -42.3% | at low | -46.7% | +21.9% | -395.4% | at low |
NKGen Biotech Warrants EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$7.13 M(-16.3%) | -$29.65 M(+3.2%) |
| Mar 2024 | - | -$8.52 M(-6.7%) | -$28.72 M(+42.2%) |
| Dec 2023 | -$29.47 M | -$9.13 M(+87.8%) | -$20.20 M(+21.3%) |
| Sept 2023 | - | -$4.86 M(-21.6%) | -$16.65 M(-6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$6.21 M(+11.2%) | -$17.77 M(+53.7%) |
| Dec 2022 | -$23.23 M(+12.2%) | -$5.58 M(-6.8%) | -$11.56 M(+93.2%) |
| Sept 2022 | - | -$5.98 M | -$5.98 M |
| Dec 2021 | -$20.70 M | - | - |
FAQ
- What is NKGen Biotech Warrants annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for NKGen Biotech Warrants?
- What is NKGen Biotech Warrants quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for NKGen Biotech Warrants?
- What is NKGen Biotech Warrants quarterly EBITDA year-on-year change?
- What is NKGen Biotech Warrants TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for NKGen Biotech Warrants?
- What is NKGen Biotech Warrants TTM EBITDA year-on-year change?
What is NKGen Biotech Warrants annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of NKGNW is -$29.47 M
What is the all time high annual EBITDA for NKGen Biotech Warrants?
NKGen Biotech Warrants all-time high annual earnings before interest, taxes, depreciation & amortization is -$20.70 M
What is NKGen Biotech Warrants quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of NKGNW is -$7.13 M
What is the all time high quarterly EBITDA for NKGen Biotech Warrants?
NKGen Biotech Warrants all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$4.86 M
What is NKGen Biotech Warrants quarterly EBITDA year-on-year change?
Over the past year, NKGNW quarterly earnings before interest, taxes, depreciation & amortization has changed by +$2.00 M (+21.91%)
What is NKGen Biotech Warrants TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of NKGNW is -$29.65 M
What is the all time high TTM EBITDA for NKGen Biotech Warrants?
NKGen Biotech Warrants all-time high TTM earnings before interest, taxes, depreciation & amortization is -$5.98 M
What is NKGen Biotech Warrants TTM EBITDA year-on-year change?
Over the past year, NKGNW TTM earnings before interest, taxes, depreciation & amortization has changed by -$9.45 M (-46.77%)